Abstract
Neoadjuvant chemotherapy in gastric cancer can treat micro metastatic disease and can increase the resectability rate. The trial was to compare early outcomes after primary surgery versus neoadjuvant chemotherapy followed by surgery in gastric adenocarcinoma. The primary aim of the study was to compare resectability and R0 resection rates in upfront surgery v/s chemotherapy followed by surgery arm. A secondary aim was to see if neoadjuvant chemotherapy is well tolerated or not by comparing postoperative morbidity and mortality. The study consisted of 60 consecutive patients of carcinoma stomach randomized into primary surgery and neoadjuvant chemotherapy followed by surgery arms. Morbidity, pathological status, and mortality data were collected and analyzed. Mean operating time in primary surgery arm was 290 ± 46.5 min, while in NACTarm, it was 316.7 ± 56.6 min, respectively. When postop complications were compared between the arms, it was not significant. Comparing the histopathological report of two groups, there was no significant difference between differentiated, T stage, mean lymph node harvest, R0 resection, PNI, and LVI. Neoadjuvant chemotherapy showed a trend towards improving in the R0 resection rate. There is no increase in postoperative morbidity and mortality with neoadjuvant chemotherapy.
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs13193-019-00908-7/MediaObjects/13193_2019_908_Fig1_HTML.png)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs13193-019-00908-7/MediaObjects/13193_2019_908_Fig2_HTML.png)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs13193-019-00908-7/MediaObjects/13193_2019_908_Fig3_HTML.png)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs13193-019-00908-7/MediaObjects/13193_2019_908_Fig4_HTML.png)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs13193-019-00908-7/MediaObjects/13193_2019_908_Fig5_HTML.png)
Similar content being viewed by others
References
Dikshit RP, Mathur G, Mhatre S, Yeole BB (2011 Jan) Epidemiological review of gastric cancer in India. Indian J Med Paediatr Oncol 32(1):3–11
Mohandas KM, Jagannath P (2000) Epidemiology of digestive tract cancers in India. VI. Projected burden in the new millennium and the need for primary prevention. Indian J Gastroenterol 19(2):74–78
Kim JP, Lee JH, Kim SJ, Yu HJ, Yang HK (1998) Clinicopathologic characteristics and prognostic factors in 10 783 patients with gastric cancer. Gastric Cancer 1(2):125–133
Sasako M, Sano T, Katai H, Maruyama K (1997) Radical surgery. In: Sugimura T, Sasaki MD (eds) Gastric cancer. Oxford University Press, Oxford, pp 223–248
Cunningham D, Allum WH, Stenning SP, Thompson JN, Van de Velde CJ et al (2006) Perioperative chemotherapy versus surgery alone for resectablegastroesophageal cancer. N Engl J Med 355(1):11–20
Y Chou M, Boige V, Pignon JP, Conroy T, Bouché O, Lebreton G, Ducourtieux M, Bedenne L, Fabre JM, Saint-Aubert B, Genève J, Lasser P, Rougier P (2011) Perioperative chemotherapy compared with surgery alone for resectablegastroesophageal adenocarcinoma: an FNCLCC and FFCD multicenter phase III trial. J Clin Oncol 29(13):1715–1721
Schuhmacher C, Gretschel S, Lordick F, Reichardt P, Hohenberger W, Eisenberger CF, Haag C, Mauer ME, Hasan B, Welch J, Ott K, Hoelscher A, Schneider PM, Bechstein W, Wilke H, Lutz MP, Nordlinger B, Cutsem EV, Siewert JR, Schlag PM (2010) Neoadjuvant chemotherapy compared with surgery alone for locally advanced cancer of the stomach and cardia: European Organisation for Research and Treatment of Cancer randomized trial 40954. J Clin Oncol 28:5210–5218
Xu AM, Huang L, Liu W, Gao S, Han WX, Wei ZJ et al (2014) Neoadjuvant chemotherapy followed by surgery versus surgery alone for gastric carcinoma: systematic review and meta-analysis of randomized controlled trials. PLoS One 9(1):e86941
Ott et al (2003) Neoadjuvant chemotherapy with cisplatin, 5- FU, and leucovorin (PLF) in locally advanced gastric cancer: a prospective phase II study. Gastric Cancer 6(3):159–167
Author information
Authors and Affiliations
Corresponding author
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Ramachandra, Goel, V., Raju, K. et al. Prospective Randomized Controlled Study Comparing Primary Surgery Versus Neoadjuvant Chemotherapy Followed by Surgery in Gastric Carcinoma. Indian J Surg Oncol 10, 245–250 (2019). https://doi.org/10.1007/s13193-019-00908-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13193-019-00908-7